C. M. Nickson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
C. M. Nickson has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
P. J. Doherty
Clinical Engineering, School of Clinical Sciences, University of Liverpool Duncan Building, Daulby Street, Liverpool, L69 3GA
1 shared publication- Rachel L. Williams
Department of Eye and Vision Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK
1 shared publication
Latest Publications
- 25 November 2008
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 24 (5) , 437-452
Novel Polymeric Coatings with the Potential to Control In-stent Restenosis — An In Vitro Study
Restenosis following percutaneous coronary intervention (PCI) is a considerable problem in long-term performance of cardiovascular stents, with a functional endothelial cell monolayer being important in its prevention. This study evaluates the influence of polymer coatings on human aortic endothelial cells (HAEC) and coronary artery smooth muscle cells (HCASMC) in vitro, in terms of morphology, cell number, and phenotype. It was demonstrated that the polymer coatings can be tailored to enhance adhesion and growth of HAECs whilst suppressing that of HCASMCs. It is concluded that one of the polymer coatings (BTL 01015) shows potential as a stent coating to enhance re-endothelialization.
- 25 November 2008
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 24 (5) , 437-452
Novel Polymeric Coatings with the Potential to Control In-stent Restenosis — An In Vitro Study
Restenosis following percutaneous coronary intervention (PCI) is a considerable problem in long-term performance of cardiovascular stents, with a functional endothelial cell monolayer being important in its prevention. This study evaluates the influence of polymer coatings on human aortic endothelial cells (HAEC) and coronary artery smooth muscle cells (HCASMC) in vitro, in terms of morphology, cell number, and phenotype. It was demonstrated that the polymer coatings can be tailored to enhance adhesion and growth of HAECs whilst suppressing that of HCASMCs. It is concluded that one of the polymer coatings (BTL 01015) shows potential as a stent coating to enhance re-endothelialization.